Regulatory Capital Financial Instruments - Schedule of Financial Instruments of Regulatory Capital Issued (Details) - CLP ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Schedule of Financial Instruments of Regulatory Capital Issued [Abstract] | ||
| Subordinated bonds with transitory recognition | ||
| Subordinated bonds | 1,068,879 | 1,039,814 |
| Bonds with no fixed term of maturity | ||
| Preferred stock | ||
| Total | $ 1,068,879 | $ 1,039,814 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of additional contingent liabilities recognised in business combinations. [Refer: Contingent liabilities recognised in business combination; Total for all business combinations [member]; Classes of contingent liabilities [domain]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of subordinated liabilities that have a specified repayment date. [Refer: Subordinated liabilities] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Adjustments to reconcile profit (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of liabilities that are subordinate to other liabilities with respect to claims. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|